Skip to content

Insider · CIK 0001598504

Eric K. Olson

ceopresidentofficerdirectorchair

Files at SINT (Sintx Technologies, Inc.). First filing Apr 30, 2025, latest Oct 21, 2025.

Eric K. Olson files SEC Form 4 as CEO, president, director and chair at SINT (Sintx Technologies, Inc.). Since Apr 30, 2025, Eric K. Olson has reported 3 open-market buys worth $85k and 0 open-market sells worth $0, the latest filed on Oct 21, 2025.

A track record needs three past buys with six months of prices behind them; Eric K. Olson has 0, so none is measured yet.

The newest scored trade: bought $20k of SINT on Oct 20, 2025, filed Oct 21, 2025, scored 44 (moderate). In the last 12 months: 1 buy worth $20k and 0 sells worth $0.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
3 / 0
$85k bought, $0 sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

SINT: Sintx Technologies, Inc.

SINTOct 9, 2026 · close 2.11

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
44Moderate
SINTbuy
Sintx Technologies, Inc.
$20k
5,800 shares
+23%+94% from low-47% from high
64Notable
SINTbuy 3
Sintx Technologies, Inc.
$37k
10,475 shares
+72%+102% from low-45% from high
71Notable
SINTbuy 3
Sintx Technologies, Inc.
$28k
14,500 shares
-+1% from low-72% from high

Transactions

Every row this insider has filed, 11 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Feb 6, 2026SINT
Sintx Technologies, Inc.
AGrant or award
Restricted Stock Unitsderivative
+100,000$0.00$0160,000Feb 10, 2026
Oct 20, 2025SINT
Sintx Technologies, Inc.
POpen-market purchase
Common Stock
+5,800$3.40$20k30,775Oct 21, 2025
Aug 22, 2025SINT
Sintx Technologies, Inc.
POpen-market purchase
Common Stock
+3,500$3.37$12k18,000Aug 25, 2025
Aug 22, 2025SINT
Sintx Technologies, Inc.
POpen-market purchase
Common Stock
+5,000$3.69$18k23,000Aug 25, 2025
Aug 22, 2025SINT
Sintx Technologies, Inc.
POpen-market purchase
Common Stock
+775$3.64$2,82123,775Aug 25, 2025
Aug 22, 2025SINT
Sintx Technologies, Inc.
POpen-market purchase
Common Stock
+1,200$3.67$4,40424,975Aug 25, 2025
Apr 22, 2025SINT
Sintx Technologies, Inc.
POpen-market purchase
Common Stock
+236$1.73$408236Apr 30, 2025
Apr 23, 2025SINT
Sintx Technologies, Inc.
POpen-market purchase
Common Stock
+3,000$1.95$5,8523,236Apr 30, 2025
Apr 23, 2025SINT
Sintx Technologies, Inc.
POpen-market purchase
Common Stock
+8,257$1.94$16k11,493Apr 30, 2025
Apr 23, 2025SINT
Sintx Technologies, Inc.
POpen-market purchase
Common Stock
+3,000$1.93$5,80114,493Apr 30, 2025
Apr 23, 2025SINT
Sintx Technologies, Inc.
POpen-market purchase
Common Stock
+7$1.98$1414,500Apr 30, 2025

Questions about Eric K. Olson

Answered from the filings on this page, as of the latest one.

Is Eric K. Olson buying or selling?

In the last 12 months Eric K. Olson reported 1 open-market buy worth $20k and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $20k of SINT on Oct 20, 2025. Grants, option exercises and tax withholding are not counted.

How did Eric K. Olson's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Eric K. Olson has 0.

Where does Eric K. Olson file Form 4?

Eric K. Olson has filed Form 4 at SINT (Sintx Technologies, Inc.) as Chairman, President and CEO. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.